Healthcare / Medical Care FacilitiesBSE
$115.00
+3.75 (+3.88%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-63.0M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
58/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$18.8B
P/E
51.3x
↑EV/EBITDA
20.5x
↑ROE
22.2%
↑Gross Margin
85.3%
↑Debt/Equity
0.40
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+25.4%
FCF CAGR
—
FCF margin
20.4%
FCF / Net income
1.34x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.06B · net income $467.3M · FCF $624.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.06B | $3.06B | $2.32B | $1.75B | $1.55B |
| Net Income | $467.3M | $467.3M | $214.3M | $303.8M | $266.9M |
| EBITDA | $930.0M | $930.0M | $599.7M | $509.5M | $444.4M |
| EPS | — | — | 1.31 | 1.86 | 1.64 |
| Gross Margin | 85.3% | 85.3% | 85.5% | 86.1% | 85.2% |
| Operating Margin | 21.7% | 21.7% | 16.4% | 21.8% | 22.2% |
| Net Margin | 15.3% | 15.3% | 9.3% | 17.3% | 17.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.40 | 0.40 | 0.54 | 0.57 | 0.44 |
| Current Ratio | 1.90 | 1.90 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $624.6M | $624.6M | $-63.0M | $-368.5M | $-117.9M |
| Returns | |||||
| ROE | 22.2% | 22.2% | 13.0% | 21.2% | 23.5% |
| Valuation | |||||
| P/E | 51.34 | 51.34 | 49.69 | — | — |
| EV/EBITDA | 20.53 | 20.53 | 19.09 | — | — |
| P/B | 8.91 | 8.91 | 6.48 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 32.0% | 32.0% | 32.0% | 13.3% | — |
| EPS Growth | — | — | -29.6% | 13.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+46.2%
Start / end P/E
n/dx → n/dx
EPS bridge
1.31 → n/d
Residual
+46.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.